Evidence map›Paper›PMID 39789404›Full record

ArticleDiscover oncology2025

The role of histone lactylation genes in hepatocellular carcinoma prognostic models and their immune cell infiltration features: a comprehensive analysis of single-cell, spatial transcriptome, Mendelian randomization and experiment.

Shanjie Luan

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Shanjie LuanShandong University School of Medicine, 44 Wenhua Xi Road, Jinan, 250012, Shandong, China. Luan20050519@163.com.ORCID http://orcid.org/0009-0002-8569-8526

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWith the increasing impact of hepatocellular carcinoma (HCC) on society, there is an urgent need to propose new HCC diagnostic biomarkers and identification models. Histone lysine lactylation (Kla) affects the prognosis of cancer patients and is an emerging target in cancer treatment. However, the potential of Kla-related genes in HCC is poorly understood.

methodsA variety of machine learning methods were used to construct and validate a model of differentially expressed Kla genes with comprehensive evaluations included ROC, Kaplan‒Meier curve, Cox regression, decision curve. Immune infiltration gathered with spatial transcriptome was performed using integrated data from multiple databases. Furthermore, single-cell analysis was used to discover the cell-cell communication and Mendelian randomization was used to study the causal relationships between immune cell and HCC. Lastly, qRT-PCR was used to verify the expression of Kla genes.

resultsWe established a model consisting of 12 genes that had well prognostic performance and were identified as independent prognostic factors. Single-cell analysis showed that CD8 T+ cells and conventional dendritic cells were enriched in HCC patients. Spatial transcriptomics analysis indicated that the Kla genes influenced the immune characteristics of HCC. Mendelian randomization results showed that TBNK and monocytes were the main risk factors. qRT-PCR validation results indicated that the expression of multiple genes in Huh7 cells was significantly higher than in LO2 cells.

conclusionOverall, a Kla-related model was established, which may provide new strategies and insights for the treatment and diagnosis of HCC.

Indexed as

Hepatocellular carcinomaHistone lactylationImmune cell infiltrationPrognostic model

Identifiers

PMID39789404
PMCPMC11717769

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.